Related Experiment Video

Updated: Oct 9, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Etiopathogenetic approach to the treatment of viral-bacterial pneumonias]

L I Nekliudova, Iu B Fedorova, N A Pasternak

    Antibiotiki
    |December 1, 1976
    PubMed

    Insights

    This study investigated leukocytal interferon aerosol combined with antibiotics for influenza A pneumonia. The combined treatment shortened illness, reduced toxicity, and improved lung healing in patients during a 1975 epidemic.

    Area of Science:

    • Virology
    • Infectious Diseases
    • Pulmonology

    Background:

    • Influenza A (Port-Chalmers virus) epidemic in 1975 featured increased viral-bacterial pneumonia.
    • Viral-staphylococcal etiology confirmed in 80% of stationary cases.
    • Staphylococcus aureus frequently co-isolated with influenza viruses.

    Purpose of the Study:

    • To evaluate the efficacy of leukocytal interferon aerosol in combination therapy for influenza A pneumonia.
    • To assess the impact of combined treatment on disease duration, intoxication, and lung tissue changes.

    Main Methods:

    • Complex treatment involving leukocytal interferon aerosol, antibacterial, and other agents.
    • Virological and serological confirmation of influenza A diagnosis.
    • Isolation and antibioticogram determination of microorganisms from patient samples (sputum, washings).

    Main Results:

    • Combined therapy significantly decreased the duration of illness.
    • Patients experienced less pronounced intoxication.
    • More rapid resorption of lung tissue changes was observed.

    Conclusions:

    • Leukocytal interferon aerosol, as part of a complex treatment, is effective against influenza A pneumonia.
    • This therapeutic approach improves clinical outcomes and radiological findings.
    • The study highlights the importance of addressing both viral and bacterial components in pneumonia treatment.

    More Related Videos

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

    Published on: September 28, 2016

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...